HMGB1 and arthritic joint disease: Administration of polyclonal anti-HMGB1 antibodies or the DNA-binding A box of HMGB1, a competitive inhibitor of the pro-inflammatory B box, can reverse the lethality of established sepsis [114, 153, 154] and ameliorate collagen-induced arthritis in rodents (reviewed in [161]).